印度制药业分析(英文).docx

印度制药业分析(英文).docx

ID:25147715

大小:1.30 MB

页数:38页

时间:2018-11-18

印度制药业分析(英文).docx_第1页
印度制药业分析(英文).docx_第2页
印度制药业分析(英文).docx_第3页
印度制药业分析(英文).docx_第4页
印度制药业分析(英文).docx_第5页
资源描述:

《印度制药业分析(英文).docx》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库

1、PHARMACEUTICALSForupdatedinformation,pleasevisitwww.ibef.orgOctober2018TableofContentExecutiveSummary3AdvantageIndia4MarketOverview6RecenttrendsandStrategies16GrowthDrivers20Opportunities30UsefulInformation…32EXECUTIVESUMMARYLeadingpharmaproducer§Indianphar

2、maceuticalindustrysuppliesover50percentofglobaldemandforvariousvaccines,40percentofgenericdemandintheUSand25percentofallmedicineinUK1.Oneofthehighestexports§Indiaaccountsfor20percentofglobalexportsingenerics.India’spharmaceuticalexportsstoodatUS$17.27billio

3、nin2017-18andareexpectedtoreachUS$20billionby2020.In2018-19theseexportsareexpectedtocrossUS$19billion.Amongfastestgrowinindustries§Thecountry’spharmaceuticalindustryisexpectedtoexpandataCAGRof22.4percentover2015–20toreachUS$55billion2.Indiaisthesecondlarges

4、tcontributorofglobalbiotechandpharmaceuticalworkforce.ThepharmaceuticalsectorwasvaluedatUS$33billionin2017.gRapidlygrowinghealthcaresector§Indianhealthcaresector,oneofthefastestgrowingsectors,isexpectedtocrossUS$372billionby2022.Highpotentialgenericsmarket§

5、ThedomesticgenericsmarketisexpectedtoreachUS$27.9billionby2020.India’sgenericsmarkethasimmensepotentialforgrowth.Indianpharmaceuticalcompaniesreceivedrecord300genericdrugapprovalsinUSAduring2017wherethegenericmarketisexpectedtoreachUS$88billionby2021.Robust

6、growthinBiotecindustry§By2024-25,India’sbiotechindustryisestimatedtoincreasetoUS$100billion.hNotes:InformationasperlatestavailabledataSource:1FICCI-Trends&OpportunitiesforIndianPharma2018,Pharmexcil,2TechSciResearch,AssochamandRNCOS3PharmaceuticalsForupdate

7、dinformation,pleasevisitwww.ibef.orgPharmaceuticalsADVANTAGEINDIAADVANTAGEINDIA5PharmaceuticalsForupdatedinformation,pleasevisitwww.ibef.org§LowcostofproductionandR&DboostsefficiencyofIndianpharmacompanies,leadingtocompetitiveexports.Indianpharmaexportsreac

8、hedUS$17.27billioninFY18.§India’scostofproductionisapproximately33percentlowerthanthatoftheUS.§India’sabilitytomanufacturehighquality,lowpricedmedicines,presentsahugebusinessopportunityforthedomesticin

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。